Trending Topic

4 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Bruton tyrosine kinase (BTK) plays a functional and integral role in B-cell receptor (BCR) signalling and is expressed in normal and malignant B cells. Given BTK’s central role in the survival and proliferation of malignant B cells, BTK inhibitors have been developed for use in various B-cell malignancies, with several US Food and Drug Administration approvals in […]

Markus Joerger, ESMO 2021: Final Results of SAKK 80/20 – COVID-19 Infection in Cancer Patients

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 5th 2021

touchONCOLOGY joins Dr Markus Joerger (St. Gallen Cancer Center, Switzerland) at ESMO 2021 to discuss the outcome and prognostic factors of COVID-19 infection in cancer patients.

Questions
1. What were the objectives of the SAKK 80/20 study? (00:15-00:50)
2. Could you give us a brief overview of the patient population of this study? (00:50-02:14)
3. What were the findings in terms of outcomes of COVID-19 infection in cancer patients?(02:14-03:57)
4. What conclusions can be made from these findings? (03:57-04:49)
5. What questions remain unanswered and what future studies are needed? (04:49-05:43)

Disclosures: Markus Joerger has no financial or non-financial conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson

Filmed in coverage of the ESMO 2021 Annual Meeting.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup